Newsroom

Newsroom

Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA as compared with BM

Literature
Read More

NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017

Press Release
Read More

NeoGenomics Schedules its Q2 2017 Earnings Release for July 25, 2017

Press Release
Read More

Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor-mutated essential thrombocythemia

Literature
Read More

Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits

Literature
Read More

An APL Case without a Detectable RARA Gene Rearrangement

Literature
Read More

BRAF mutation and PD-L1 expression in melanoma: Comparison between multiple PD-L1 IHC clones and BRAF mutation evaluated by FDA-approved kits versus NGS

Literature
Read More

Expression of PD-L1 in colorectal cancer that lack mutations in RAS or TP53 genes

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients